Sorenson Corinna, Drummond Michael, Bhuiyan Khan Beena
LSE Health, London School of Economics and Political Science, London, UK; ; European Health Technology Institute for Socioeconomic Research, Brussels, Belgium;
Clinicoecon Outcomes Res. 2013 May 30;5:223-34. doi: 10.2147/CEOR.S39634. Print 2013.
Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing literature, with the aim of offering a more detailed and considered analysis of this relationship. Several databases were searched to identify relevant literature. Various categories of studies (eg, multivariate and cost-effectiveness analyses) were included to cover different perspectives, methodological approaches, and issues regarding the link between medical technology and costs. Selected articles were reviewed and relevant information was extracted into a standardized template and analyzed for key cross-cutting themes, ie, impact of technology on costs, factors influencing this relationship, and methodological challenges in measuring such linkages. A total of 86 studies were reviewed. The analysis suggests that the relationship between medical technology and spending is complex and often conflicting. Findings were frequently contingent on varying factors, such as the availability of other interventions, patient population, and the methodological approach employed. Moreover, the impact of technology on costs differed across technologies, in that some (eg, cancer drugs, invasive medical devices) had significant financial implications, while others were cost-neutral or cost-saving. In light of these issues, we argue that decision-makers and other commentators should extend their focus beyond costs solely to include consideration of whether medical technology results in better value in health care and broader socioeconomic benefits.
在大多数国家,医疗保健支出一直在稳步上升,这已成为全球决策者关注的问题。评论家们常常指出,新的医疗技术是支出迅速增长的关键驱动因素。本文基于对现有文献的分析,对这一推测进行了批判性评估,旨在对这种关系进行更详细、更周全的分析。检索了几个数据库以确定相关文献。纳入了各类研究(如多变量分析和成本效益分析),以涵盖不同的视角、方法途径以及有关医疗技术与成本之间联系的问题。对所选文章进行了综述,并将相关信息提取到一个标准化模板中,分析其中关键的贯穿各领域的主题,即技术对成本的影响、影响这种关系的因素以及衡量此类联系时的方法挑战。总共审查了86项研究。分析表明,医疗技术与支出之间的关系复杂且常常相互矛盾。研究结果往往取决于多种因素,如其他干预措施的可用性、患者群体以及所采用的方法途径。此外,不同技术对成本的影响也有所不同,一些技术(如抗癌药物、侵入性医疗器械)具有重大财务影响,而其他技术则成本中性或节省成本。鉴于这些问题,我们认为决策者和其他评论家应将关注点从单纯的成本扩展到包括考量医疗技术是否能带来更高的医疗保健价值以及更广泛的社会经济效益。